Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 mutational cascades and the risk of hyper-exponential growth
John M. Halley, Despoina Vokou, Γεώργιος Παππάς, et al.
Microbial Pathogenesis (2021) Vol. 161, pp. 105237-105237
Open Access | Times Cited: 13

Showing 13 citing articles:

Real-Word Effectiveness of Global COVID-19 Vaccines Against SARS-CoV-2 Variants: A Systematic Review and Meta-Analysis
Kai Wang, Lin Wang, Mingzhe Li, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 33
Antivirals for Broader Coverage against Human Coronaviruses
Mia Outteridge, Christine M. Nunn, Kevin M. Devine, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 156-156
Open Access | Times Cited: 4
SARS-CoV-2 as a Zooanthroponotic Infection: Spillbacks, Secondary Spillovers, and Their Importance
Γεώργιος Παππάς, Despoina Vokou, Ioannis Sainis, et al.
Microorganisms (2022) Vol. 10, Iss. 11, pp. 2166-2166
Open Access | Times Cited: 18
Severe acute respiratory syndrome Coronavirus-2 GenoAnalyzer and mutagenic anomaly detector using FCMFI and NSCE
Shivendra Dubey, Dinesh Kumar Verma, Mahesh Kumar
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 129051-129051
Closed Access | Times Cited: 9
Vaccine third dose and cancer patients: necessity or luxury?
Γεώργιος Παππάς, Emmanouil Saloustros, Anastasios Boutis, et al.
ESMO Open (2021) Vol. 6, Iss. 6, pp. 100306-100306
Open Access | Times Cited: 9
Endogenous viral mutations, evolutionary selection, and containment policy design
Patrick Mellacher
Journal of Economic Interaction and Coordination (2022) Vol. 17, Iss. 3, pp. 801-825
Open Access | Times Cited: 6
Country-level factors dynamics and ABO/Rh blood groups contribution to COVID-19 mortality
A. Monaco, Ester Pantaleo, Nicola Amoroso, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Molecular Dynamics Simulations Suggest SARS-CoV-2 3CLpro Mutations in Beta and Omicron Variants Do Not Alter Binding Affinities for Cleavage Sites of Non-Structural Proteins
Vitor Martins de Freitas Amorim, Robson Francisco de Souza, Cristiane Rodrigues Guzzo, et al.
COVID (2023) Vol. 3, Iss. 4, pp. 622-636
Open Access | Times Cited: 2
Molecular Dynamics Simulations Suggest Sars-Cov-2 3clpro Mutations in Beta and Omicron Variants do not Alter Binding Affinities for Cleavage Sites of Non-Structural Proteins
Vitor Martins De Freitas Amorim, Robson Francisco de Souza, Cristiane Rodrigues Guzzo, et al.
(2023)
Open Access | Times Cited: 2
Birds and mammals have natural selection regulated population dynamics
Lars Witting
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
The “Invisible Enemy” SARS-CoV-2: Viral Spread and Drug Treatment
Alina Tănase, Aniko Maria Manea, Alexandra-Denisa Semenescu, et al.
Medicina (2022) Vol. 58, Iss. 2, pp. 261-261
Open Access | Times Cited: 3
Antivirals and Biologics for Broader Coverage Against Human Coronaviruses
Mia Outteridge, Christine M. Nunn, Kevin M. Devine, et al.
(2023)
Open Access | Times Cited: 1
Modeling Mutation-Driven Emergence of Drug-Resistance: A Case Study of SARS-CoV-2
Congjie Shi, Thomas N. Vilches, Ao Li, et al.
Fields Institute communications (2023), pp. 161-174
Closed Access
Page 1

Scroll to top